Balancing Bleeding and Thrombosis in Lung Adenocarcinoma – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Thomas Fusillo et al. published in JTH, adding:
“Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and VEGF or EGFR inhibitors
Clinicians often worry about combining anticoagulation with targeted cancer drugs.
In patients with lung adenocarcinoma, giving anticoagulants alongside VEGF or EGFR inhibitors was not associated with a statistically significant rise in major or clinically relevant non-major bleeding.
The data offer some reassurance for treating thrombosis in this group, though careful patient selection still applies.”
Title: Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors
Authors: Thomas F. Fusillo, Avi Leader, Simon Mantha, Helen Ajufo, Andriy Derkach, Adam Schoenfeld, Rohan Singh, Peter Kaplinsky, Jeffrey I. Zwicker
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 5, 2026, 02:35Balaji Balagani: Exploring Stable vs Unstable vs Complete Coronary Block
-
Sep 5, 2026, 02:28N. Mariana S. Vasquez: Warm vs Cold Autoimmune Hemolytic Anemia for USMLE/NBME Questions
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism
-
Sep 4, 2026, 21:54Gianluca Costamagna: Investigating the Link Between Cancer and Acute Ischemic Stroke
-
Sep 4, 2026, 21:50Ben Creagh-Brown: PRAGUE-26 and HI-PEITHO Similar Benefits With Important Differences
-
Sep 4, 2026, 21:48Jin-Xiong She: Homocysteine beyond Heart Disease – The Methylation-Mobility Connection
-
Sep 4, 2026, 21:44Aravind Palraj: Anemia of Chronic Inflammation is Not Just “Iron Deficiency”